Overview

Clinical Trial of Efficacy and Safety of Anaferon in the Treatment of Acute Respiratory Viral Infections

Status:
Completed

Trial end date:
2019-03-15

Target enrollment:

Participant gender:

Summary

Purpose of the study: • To obtain additional data on the efficacy and safety of Anaferon in the treatment of acute respiratory viral infections.

Phase:

Phase 4

Details

Lead Sponsor:

Materia Medica Holding